Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease

Journal of Cutaneous Pathology

Volumn 34, Issue 1, 2007, Pages 33-38

  Liu, Houjun ^a,b   Urabe, Kazunori ^a   Uchi, Hiroshi ^a   Takeuchi, Satoshi ^a   Nakahara, Takeshi ^a   Dainichi, Teruki ^a   Tu, Yating ^b   Furue, Masutaka ^a   Moroi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

STAT5A PROTEIN; UVOMORULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PAGET SKIN DISEASE; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; CADHERINS; DERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAGET'S DISEASE, EXTRAMAMMARY; PROGNOSIS; SINGLE-BLIND METHOD; STAINING AND LABELING; STAT5 TRANSCRIPTION FACTOR; TISSUE DISTRIBUTION;

EID: 33846093941     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00568.x     Document Type: Article

References (26)

1. Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000; 19: 2468.
2. Gouilleux F, Wakao H, Mundt M, Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994; 13: 4361.
3. Wakao H, Gouilleux F, Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 1994; 13: 2182.
4. Onishi M, Nosaka T, Misawa K, et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 1998; 18: 3871.
5. Humphreys RC, Hennighausen L. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ 1999; 10: 685.
6. Ren S, Cai HR, Li M, Furth PA. Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene 2002; 21: 4335.
7. Cotarla I, Ren S, Zhang Y, et al. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer 2004; 108: 665.
8. Nevalainen MT, Xie J, Torhorst J, et al. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 2004; 22: 2053.
9. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987.
10. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57.
11. Fearon ER. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell 2003; 3: 307.
12. Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003; 19: 207.
13. Chiles MC, Ai L, Zuo C, Fan CY. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Mod Pathol 2003; 16: 1014.
14. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002; 34: 255.
15. Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53: 742.
16. Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol 2000; 142: 243.
17. Liu H, Moroi Y, Masuda T, et al. Expression of p-Stat3, cyclin D1 and Bcl-xL in extramammary Paget's disease. Br J Dermatol 2006; 154: 926.
18. Hennighausen L, Robinson GW. Signaling pathways in mammary gland development. Dev Cell 2001; 1: 467.
19. Nosaka T, Kawashima T, Misawa K, et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J 1999; 18: 4754.
20. Buitenhuis M, Baltus B, Lammers JW, Coffer PJ, Koenderman L. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood 2003; 101: 134.
21. Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247.
22. Iavnilovitch E, Groner B, Barash I. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 2002; 1: 32.
23. Sultan AS, Xie J, LeBaron MJ, et al. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005; 24: 746.
24. Wu H, Lotan R, Menter D, Lippman SM, Xu XC. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res 2000; 20: 1385.
25. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol 2004; 26: 372.
26. Tada H, Hatoko M, Muramatsu T, Shirai T. Expression of E-cadherin in skin carcinomas. J Dermatol 1996; 23: 104.